NTRB - Nutriband Inc logo

NTRB

Nutriband Inc

Nutriband Inc. develops transdermal pharmaceutical products, focusing on abuse-deterrent systems like AVERSA fentanyl for chronic pain management. Its pipeline includes buprenorphine and methylphenidate patches, targeting safer medication delivery solutions.

โš•๏ธ Healthcare NASDAQ Listed 2017 $ USD
$1,000 invested 5 years ago โ†’$399today

Score Overview

1 Year
Score
Net Growth1.79%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-11.49%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score5.1
Net Growth4.03%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth26.75%
Rev Trend60%
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-202.50%
Net Trend44%
Net Income Consistency
Rev Growthโ€”
Rev Trend78%
Revenue Consistency

See the full market ranking โ†’

Nutriband Inc fundamental performance

Between 2021 and 2026, revenue grew from $ 943.7K to $ 2M and net income went from -$ 3M to -$ 8M. Revenue increased in 3 of those 5 years; net income in 3.

Nutriband Inc currently holds a 5-year HDB Score of 5.1 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 3.08โ€”
1 Year2025-08-12
$ 6.80-54.78%
5 Years2021-07-28
$ 7.71-60.14%
All Time2017-11-30
$ 5.66-45.64%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2027$ 1M-$ 8M$ 4M
2026$ 2M-$ 8M$ 4M
2025$ 2M-$ 10M$ 4M
2024$ 2M-$ 5M$ 492.94K
2023$ 2M-$ 4M$ 1M
2022$ 1M-$ 8M$ 4M
2021$ 943.7K-$ 3M$ 151.99K
2020$ 370.65K-$ 2M$ 10.18K
2019$ 245.28K-$ 3M$ 474.65K
2018$ 0.00-$ 2M

Explore beyond NTRB

You're looking at Nutriband Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies